These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 12605353
21. L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings. Evans AH, Costa DC, Gacinovic S, Katzenschlager R, O'sullivan JD, Heales S, Lee P, Lees AJ. Mov Disord; 2004 Oct; 19(10):1232-6. PubMed ID: 15390012 [Abstract] [Full Text] [Related]
22. 99mTc-TRODAT-1 imaging of multiple system atrophy. Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, Ting G, Chang HC, Yen TC. J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673 [Abstract] [Full Text] [Related]
23. A second-generation 99m technetium single photon emission computed tomography agent that provides in vivo images of the dopamine transporter in primate brain. Meltzer PC, Blundell P, Zona T, Yang L, Huang H, Bonab AA, Livni E, Fischman A, Madras BK. J Med Chem; 2003 Jul 31; 46(16):3483-96. PubMed ID: 12877586 [Abstract] [Full Text] [Related]
24. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB. J Nucl Med; 1996 Jul 31; 37(7):1129-33. PubMed ID: 8965183 [Abstract] [Full Text] [Related]
25. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Jeon BS, Jeong JM, Park SS, Kim JM, Chang YS, Song HC, Kim KM, Yoon KY, Lee MC, Lee SB. Ann Neurol; 1998 Jun 31; 43(6):792-800. PubMed ID: 9629849 [Abstract] [Full Text] [Related]
26. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease. Covelli EM, Brunetti A, Di Lauro A, Sullo P, Mazzarella G, Tedeschi E, Belfiore G. Radiol Med; 2004 Oct 31; 108(4):417-25. PubMed ID: 15525895 [Abstract] [Full Text] [Related]
27. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, Pupi A, European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging; 2002 Oct 31; 29(10):BP30-5. PubMed ID: 12436496 [No Abstract] [Full Text] [Related]
28. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS. J Nucl Med; 2004 Mar 31; 45(3):393-401. PubMed ID: 15001678 [Abstract] [Full Text] [Related]
29. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1. Hu P, Chen L, Zhang HQ, Li JR, Liang H. Chin Med J (Engl); 2004 Jul 31; 117(7):1056-9. PubMed ID: 15265382 [Abstract] [Full Text] [Related]
30. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders]. Kanyó B, Argyelán M, Dibó G, Szakonyi Z, Vécsei L, Fülöp F, Láncz A, Forgács P, Pávics L. Ideggyogy Sz; 2003 Jul 20; 56(7-8):231-40. PubMed ID: 12971118 [Abstract] [Full Text] [Related]
31. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects. Kim HJ, Im JH, Yang SO, Moon DH, Ryu JS, Bong JK, Nam KP, Cheon JH, Lee MC, Lee HK. J Nucl Med; 1997 Nov 20; 38(11):1703-11. PubMed ID: 9374337 [Abstract] [Full Text] [Related]
33. Extrastriatal uptake related to dopaminergic dysfunction on 99mTc-TRODAT-1 brain SPECT in patient with atypical meningioma. Hou PN, Huang YE, Chan SH. Hell J Nucl Med; 2023 Nov 20; 26(3):210-214. PubMed ID: 38085837 [Abstract] [Full Text] [Related]
34. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia. Hwang WJ, Yao WJ, Wey SP, Ting G. Eur Neurol; 2004 Nov 20; 51(1):26-9. PubMed ID: 14631126 [Abstract] [Full Text] [Related]
35. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T. J Nucl Med; 2000 Jan 20; 41(1):36-44. PubMed ID: 10647603 [Abstract] [Full Text] [Related]
36. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. Mozley PD, Stubbs JB, Plössl K, Dresel SH, Barraclough ED, Alavi A, Araujo LI, Kung HF. J Nucl Med; 1998 Dec 20; 39(12):2069-76. PubMed ID: 9867143 [Abstract] [Full Text] [Related]
37. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB. J Nucl Med; 1998 Sep 20; 39(9):1500-8. PubMed ID: 9744331 [Abstract] [Full Text] [Related]
38. An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1. Choi SR, Kung MP, Plössl K, Meegalla S, Kung HF. Nucl Med Biol; 1999 May 20; 26(4):461-6. PubMed ID: 10382851 [Abstract] [Full Text] [Related]
39. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. Booij J, Hemelaar TG, Speelman JD, de Bruin K, Janssen AG, van Royen EA. J Nucl Med; 1999 May 20; 40(5):753-61. PubMed ID: 10319746 [Abstract] [Full Text] [Related]
40. 123I-beta-CIT SPECT for imaging serotonin transporters in Parkinson's disease. Barthel H, Hesse S, Sabri O. J Nucl Med; 2004 May 20; 45(5):923-4. PubMed ID: 15136646 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]